123 related articles for article (PubMed ID: 31229409)
1. Influence of lipid composition on the ability of liposome loaded voacamine to improve the reversion of doxorubicin resistant osteosarcoma cells.
Giansanti L; Condello M; Altieri B; Galantini L; Meschini S; Mancini G
Chem Phys Lipids; 2019 Sep; 223():104781. PubMed ID: 31229409
[TBL] [Abstract][Full Text] [Related]
2. Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.
Condello M; Cosentino D; Corinti S; Di Felice G; Multari G; Gallo FR; Arancia G; Meschini S
J Nat Prod; 2014 Apr; 77(4):855-62. PubMed ID: 24720452
[TBL] [Abstract][Full Text] [Related]
3. The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells.
Meschini S; Condello M; Calcabrini A; Marra M; Formisano G; Lista P; De Milito A; Federici E; Arancia G
Autophagy; 2008 Nov; 4(8):1020-33. PubMed ID: 18838862
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
[TBL] [Abstract][Full Text] [Related]
5. Voacamine: Alkaloid with its essential dimeric units to reverse tumor multidrug resistance.
Condello M; Pellegrini E; Multari G; Gallo FR; Meschini S
Toxicol In Vitro; 2020 Jun; 65():104819. PubMed ID: 32135239
[TBL] [Abstract][Full Text] [Related]
6. Effects of lipid composition on the properties of doxorubicin-loaded liposomes.
Sakai-Kato K; Nanjo K; Kawanishi T; Okuda H; Goda Y
Ther Deliv; 2015 Jul; 6(7):785-94. PubMed ID: 26228772
[TBL] [Abstract][Full Text] [Related]
7. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G
Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216
[TBL] [Abstract][Full Text] [Related]
8. New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.
Haghiralsadat F; Amoabediny G; Sheikhha MH; Zandieh-Doulabi B; Naderinezhad S; Helder MN; Forouzanfar T
Chem Biol Drug Des; 2017 Sep; 90(3):368-379. PubMed ID: 28120466
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive cationic liposome for endosomal escape mediated drug delivery.
Rayamajhi S; Marchitto J; Nguyen TDT; Marasini R; Celia C; Aryal S
Colloids Surf B Biointerfaces; 2020 Apr; 188():110804. PubMed ID: 31972443
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells.
Meschini S; Condello M; Marra M; Formisano G; Federici E; Arancia G
Toxicol In Vitro; 2007 Mar; 21(2):197-203. PubMed ID: 17070665
[TBL] [Abstract][Full Text] [Related]
11. Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells.
Meschini S; Marra M; Calcabrini A; Federici E; Galeffi C; Arancia G
Int J Oncol; 2003 Dec; 23(6):1505-13. PubMed ID: 14612920
[TBL] [Abstract][Full Text] [Related]
12. pH sensitive liposomes delivering tariquidar and doxorubicin to overcome multidrug resistance of resistant ovarian cancer cells.
Xia Y; Fang M; Dong J; Xu C; Liao Z; Ning P; Zeng Q
Colloids Surf B Biointerfaces; 2018 Oct; 170():514-520. PubMed ID: 29960952
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
14. High-performance thin-layer chromatography for the evaluation of voacamine intracellular concentration related to its cytotoxic effect.
Condello M; Multari G; Gallo FR; Arancia G; Meschini S
J Pharm Biomed Anal; 2015 Nov; 115():467-74. PubMed ID: 26298394
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?
Hattinger CM; Fanelli M; Tavanti E; Vella S; Riganti C; Picci P; Serra M
Future Oncol; 2017 Apr; 13(8):673-677. PubMed ID: 28183198
[No Abstract] [Full Text] [Related]
16. New pH-responsive gemini lipid derived co-liposomes for efficacious doxorubicin delivery to drug resistant cancer cells.
Moitra P; Kumar K; Sarkar S; Kondaiah P; Duan W; Bhattacharya S
Chem Commun (Camb); 2017 Jul; 53(58):8184-8187. PubMed ID: 28678285
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.
Gazzano E; Buondonno I; Marengo A; Rolando B; Chegaev K; Kopecka J; Saponara S; Sorge M; Hattinger CM; Gasco A; Fruttero R; Brancaccio M; Serra M; Stella B; Fattal E; Arpicco S; Riganti C
Cancer Lett; 2019 Aug; 456():29-39. PubMed ID: 31047947
[TBL] [Abstract][Full Text] [Related]
18. SIAH1/ZEB1/IL-6 axis is involved in doxorubicin (Dox) resistance of osteosarcoma cells.
Han X; Liu F; Zhang C; Ren Z; Li L; Wang G
Biol Chem; 2019 Mar; 400(4):545-553. PubMed ID: 30265649
[TBL] [Abstract][Full Text] [Related]
19. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
Hu T; Fei Z; Su H; Xie R; Chen L
Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
[TBL] [Abstract][Full Text] [Related]
20. EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.
Haghiralsadat F; Amoabediny G; Naderinezhad S; Nazmi K; De Boer JP; Zandieh-Doulabi B; Forouzanfar T; Helder MN
Pharm Res; 2017 Dec; 34(12):2891-2900. PubMed ID: 29110283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
